insulin

Top 7 Worst Customer Stories
Top 7 Worst Customer StoriesThe worst of the worst customers that our readers have had the (dis)pleasure of helping.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Nine ways to help diabetic patients complyGetting diabetic patients to adhere to medication and dietary changes can be difficult. Here are some tips from experts.
New therapies show promise in treating diabetes
New therapies show promise in treating diabetesNew updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.
Insulin makers accused of price collusionU.S. congressmen last week asked the Department of Justice and the Federal Trade Commission to investigate three insulin makers for price collusion—the latest in concerns over insulin prices.
Importance of adherence and follow-up in patients with diabetic retinopathyA 37-year-old male came to my office for the first time in 2014 for a diabetes eye examination at the insistence of his primary-care provider (PCP).
Remicade will now have a biosimilarExpert: Expectations are high that biosimilars can control overall biologic cost growth.
Biosimilar drugs appear comparable to brand-name counterpartsSystematic review provides comprehensive first look at TNF-alpha biosimilar treatments.
Overtreating glucose levels can take a toll on diabetes patientsMayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.
Diabetes drug Tresiba to make billionsTresiba, the long-acting insulin that just came on the market in January, stands to net Novo Nordisk billions of dollars.